Jeanine Stratton

Jeanine Stratton

Auto-generated profile, based on publicly available information

Jeanine Stratton

Furman University, Greenville, SC, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MCMelanie J Cozad
Melanie J Cozad
MCMarissa Crum
Marissa Crum
HTHannah Tyson
Hannah Tyson
PFPerry R Fleming
Perry R Fleming
JSJeanine Stratton
Jeanine Stratton
RHRonnie D Horner
Ronnie D Horner
Background: Rheumatoid arthritis (RA) is a highly dynamic and individualized disease in terms of its patterns of symptomatic flare-ups and periods of remission. Patient-centered care (PCC) aligns patients’ lifestyle goals with their preferences for managing symptoms and side effects through the selection of therapies appropriate for disease management. Mobile health (mHealth) apps have the potential to engage and activate patients in PCC. mHealth apps can provide features that increase disease knowledge, collect patient-generated health indicators and behavioral metrics, and highlight goals for disease management. However, little evidence-based guidance exists as to which apps contain functionality essential for supporting the delivery of PCC. Objective: The objective of this study was to evaluate the patient-centeredness of United States–based rheumatoid arthritis mobile apps in terms of patient engagement and activation. Methods: A search of mobile apps on 2 major United States app stores (Apple App Store and Google Play) was conducted from June 2020 to July 2021 to identify apps designed for use by patients with RA by adapting the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines for mobile health app screening based on the literature. Reviewers conducted a content analysis of mobile app features to evaluate their functionality for patient engagement and activation. Engagement and activation were assessed using the Mobile Application Rating Scale (MARS) and social cognitive theory, respectively. Apps were ranked by their ability to facilitate PCC care along 2 dimensions: engagement and activation. Results: A total of 202 mobile apps were initially identified, and 20 remained after screening. Two apps emerged with the greatest ability to facilitate PCC. Both apps were scored as having acceptable or good patient engagement according to the MARS. These 2 apps also had high patient activation according to social cognitive theory, with many features within those apps representing theoretical constructs such as knowledge, perceived self-efficacy, and expectations about outcomes that support behavioral management of RA. Conclusions: We found very few mobile apps available within the United States that have functionality that both engages and activates the patient to facilitate PCC. As the prevalence of mobile apps expands, the design of mobile apps needs to integrate patients to ensure that their functionality promotes engagement and activation. More research is needed to understand how mobile app use impacts patient engagement and activation, and ultimately, treatment decisions and disease trajectory.

26 May 2022 in JMIR Preprints
Verified
Preprint
Open access
MCMelanie Cozad
Melanie Cozad
MCMarissa Crum
Marissa Crum
HTHannah Tyson
Hannah Tyson
PFPerry Fleming
Perry Fleming
JSJeanine Stratton
Jeanine Stratton
RHRonnie D. Horner
Ronnie D. Horner
BACKGROUND Rheumatoid arthritis (RA) is highly dynamic and individualized disease in terms of its patterns of flare ups in symptoms and periods of remission. Patient-centered care (PCC) aligns patients’ lifestyle goals and their preferences for managing symptoms and side-effects with the selection of therapies appropriate for disease management. Mobile health (mHealth) applications hold the potential to engage and activate patients in PCC. mHealth apps can provide features that increase disease knowledge, collect patient-generated health indicators and behavioral metrics, and highlight goals for disease management. However, little evidence-based guidance exists as to which apps contain functionality essential for supporting the delivery of PCC. OBJECTIVE This study systematically evaluated United States-based, RA mobile application features to assess functionality to facilitate engagement and activation related to PCC. METHODS A systematic search of mobile applications on two major United States app stores, (Apple App Store and Google Play) was conducted from June 2020 to July 2021 to identify apps designed for use by patients with RA using the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. Reviewers conducted a content analysis of mobile app features to evaluate their functionality for patient engagement and activation. Engagement and activation were assessed using the Mobile Application Rating Scale (MARS) and social cognitive theory, respectively. Apps were ranked by their ability to facilitate PCC care along each dimension: engagement and activation. RESULTS A total of 202 mobile applications were initially identified, and 20 applications remained after PRISMA guidelines were applied. Two applications emerged with the greatest ability to facilitate PCC. Both applications were scored as having acceptable or good patient engagement according to the MARS. These two apps also had high patient activation according to social cognitive theory with many features within those apps representing theoretical constructs such as knowledge, perceived self-efficacy, and expectations about outcomes that support behavioral management of RA. CONCLUSIONS We found very few mobile applications available within the United States that have functionality that both engages and activates the patient to facilitate PCC. As the prevalence of mobile applications expands, the design of mobile applications needs to integrate patients to ensure their functionality promotes engagement and activation. More research is needed to understand how mobile application use impacts patient engagement and activation, and ultimately, treatment decisions and disease trajectory.

11 October 2026 in Behavior Modification
Verified
Journal Article
Open access
KWKatie Wolfe
Katie Wolfe
LLLauren M. LeJeune
Lauren M. LeJeune
JGJessie D. Guest
Jessie D. Guest
ASAdrianna M. Shoemaker
Adrianna M. Shoemaker
JSJeanine P. Stratton
Jeanine P. Stratton
HGHannah C. Gates
Hannah C. Gates
Although visual analysis is integral to evaluating intervention effects in single-case research, little is known about how researchers actually use this method. Previous research on visual analysis has focused on the decisions that researchers make but has not examined how researchers use visual analysis to make those decisions. In this qualitative study, we used a think-aloud protocol and asked 15 researchers to verbalize their analysis as they viewed published multiple baseline design graphs. We analyzed transcripts using Consensual Qualitative Research (CQR). Contrary to previous research on the reporting of visual analysis in published manuscripts, researchers frequently described level, trend, and variability. However, they discussed data sufficiency and covariation across tiers less often. Implications for future research include extending the think-aloud protocol to compare the analytic process across design types and expertise levels. Our findings may also contribute to the development or refinement of protocols for training visual analysis that are rooted in expert consensus.